G(M1)-gangliosidosis is a lysosomal storage disease characterized by the accumulation of G(M1) ganglioside in neurons, including retinal ganglion cells (RGCs). Although vision impairment and retinal degeneration are well-known manifestations in humans, knowledge about the underlying mechanism of these lesions is limited. Pathological retinal changes in a Glb1 knockout (Glb1(-/-)) mouse model were assessed using immunohistochemistry, immunofluorescence and transmission electron microscopy in 4- and 7-month-old wild type and Glb1 knockout (Glb1(-/-)) mice. Increased numbers of glial fibrillary acidic protein (GFAP) positive Müller cells (MCs) were detected in Glb1(-/-) mice both at 4 and 7 months of age, indicating glial reactivity. A transient increase in glutamine synthetase (GS) positive MCs at 4 months of age with a subsequent decrease by 7 months, most likely related to reduced expression of GS, was also observed. Immunohistochemistry revealed loss of RGCs, storage material accumulation and decreased BRN3A expression in 7-month-old Glb1(-/-) mice. Increasing numbers of Iba1-positive microglia/macrophages were detected in Glb1(-/-) mice at both time points. Microglia/macrophages showed migration towards the inner retinal layers and acquired a morphological phenotype that indicates activation. The present study shows that the murine G(M1) model used in this study is suitable for investigating ocular changes in lysosomal storage diseases.
Novel insights into pathomechanisms of retinal neuronal degeneration and reactive gliosis in a murine model of G(M1)-gangliosidosis.
在 G(M1) 神经节苷脂沉积症小鼠模型中,对视网膜神经元变性和反应性胶质增生的发病机制有了新的认识
阅读:15
作者:Jubran Lorna, Wannemacher Rouven, Ulianytska Anastasiia, Gerhauser Ingo, Baumgärtner Wolfgang, Leitzen Eva
| 期刊: | Scientific Reports | 影响因子: | 3.900 |
| 时间: | 2025 | 起止号: | 2025 Aug 13; 15(1):29674 |
| doi: | 10.1038/s41598-025-15639-9 | 研究方向: | 神经科学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
